Enabled by telehealth platforms and direct-to-consumer models, compounded GLP-1s gained significant traction during the shortage period
Extended room temperature exposure is a different story
AT A GLANCE Originally FDA-approved for type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) also lead to sustained weight loss and have revolutionized diabetes and obesity management
3,4 American Association of Clinical Endocrinology guidelines recommend treatment with GLP-1RA in T2DM patients with coexisting ASCVD, high-risk for ASCVD, heart failure, or chronic kidney disease regardless of their glycemic control due to their organ protective effects
Sjstrm, L., Lindroos, A.K., Peltonen, M., et al
Some studies suggest these drugs might help control inflammation and cell growth in ways that could be beneficial